RecruitingNCT05679284

A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

The Prevalence and Predisposing Factors to Retained Drug Needle Fragments in People Who Inject Drugs: a Protocol for a Cross-sectional Observational Study


Sponsor

Tampere University Hospital

Enrollment

100 participants

Start Date

May 25, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

In addition to the well-known toxicological harms of intravenous drug (IVD) use, there can also be local tissue complications, including infections, venous sclerosis, tissue necrosis, and drug needle fragment retentions. Drug needle fragments in subcutaneous tissue may cause local symptoms (usually pain and infections), but they have also been identified as causing emboli to organs. The literature has described numerous case reports of people who inject drugs (PWIDs) and have retained needle fragments. The prevalence of the condition is not known, and the researchers therefore aim to perform the first cross-sectional study of PWIDs to estimate how common needle fragment retentions are and what their risk factors are in this population.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at how often people who use intravenous (IV) drugs have broken needle fragments left inside their body — and where those fragments end up. You may be eligible if you: - Have a history of intravenous drug use - Are currently in treatment at a local low-threshold drug service or primary healthcare centre - Are willing to fill out a questionnaire and have X-ray imaging done of injection sites - Are 18 years of age or older You may NOT be eligible if you: - Have no history of intravenous drug use - Refuse to complete the questionnaire or X-ray imaging - Are pregnant - Are under 18 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONLow-dose X-ray of subcutaneous tissues

To identify needle fragment retentions, the radiologic imaging of all volunteers will be performed with X-ray using radiation doses as low as reasonably achievable (ALARA) and one projection per anatomic site.


Locations(1)

Hatanpää Health Center

Tampere, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05679284


Related Trials